Perillyl alcohol-mediated inhibition of lung cancer cell line proliferation: potential mechanisms for its chemotherapeutic effects
Author:
Publisher
Elsevier BV
Subject
Pharmacology,Toxicology
Reference62 articles.
1. Transforming growth factor beta and cell cycle regulation;Alexandrow;Cancer Res.,1995
2. A phase II trial of daily perillyl alcohol in patients with advanced ovarian cancer: Eastern Cooperative Oncology Group Study E2E96;Bailey;Gynecol. Oncol.,2002
3. Monoterpenes inhibit cell growth, cell cycle progression, and cyclin D1 gene expression in human breast cancer cell lines;Bardon;Nutr. Cancer,1998
4. Monoterpenes inhibit proliferation of human colon cancer cells by modulating cell cycle-related protein expression;Bardon;Cancer Lett.,2002
5. Inhibitory effects of perillyl alcohol on UVB-induced murine skin cancer and AP-1 transactivation;Barthelman;Cancer Res.,1998
Cited by 43 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Molecular pharmacology and therapeutic advances of monoterpene perillyl alcohol;Phytomedicine;2024-09
2. Enhancing Oral Bioavailability and Brain Biodistribution of Perillyl Alcohol Using Nanostructured Lipid Carriers;Pharmaceuticals;2023-07-25
3. Quantification of promoting efficiency and reducing toxicity of Traditional Chinese Medicine: A case study of the combination of Tripterygium wilfordii hook. f. and Lysimachia christinae hance in the treatment of lung cancer;Frontiers in Pharmacology;2022-10-20
4. Perillyl alcohol as a treatment for cancer: A systematic review;Phytomedicine Plus;2021-08
5. Viable route and DFT study for the synthesis of optically active limonaketone: A barely available natural feedstock in Cedrus atlantica;Journal of Molecular Structure;2021-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3